FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Muscular strength and good physical fitness linked to lower risk of death in people with cancer

2.

Inner Thoughts of Leonard Bernstein, the "Maestro".

3.

Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer

4.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

5.

Error on the MGUS-Autoimmune Disease Association.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot